RT Book, Section
A1 Vest, Amanda R.
A2 Baliga, R. R.
A2 Abraham, William T.
SR Print(0)
ID 1161015263
T1 Obesity and the Obesity Paradox
T2 Color Atlas and Synopsis of Heart Failure
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071749381
LK accesscardiology.mhmedical.com/content.aspx?aid=1161015263
RD 2024/04/20
AB A  48-year-old  man  with  nonischemic  cardiomyopathy  (left  ventricular  ejection  fraction  [LVEF]  20%)  presents  for  subspecialty  heart  failure  evaluation.  He  has  a  history  of  multiple  decompensated  heart  failure  hospitalizations  (4  within  the  past  year),  episodes  of  ventricular  tachycardia,  hypertension,  hyperlipidemia,  hypothyroidism,  a  thromboembolic  stroke  with  no  residual  neurological  deficit,  atrial  fibrillation,  sleep  apnea,  and  deep  vein  thrombosis.  His  weight  at  the  time  of  evaluation  is  162  kg  (358  lb);  he  is  volume  overloaded  in  clinic,  but  after  inpatient  diuresis  his  dry  weight  is  established  at  156  kg,  giving  a  body  mass  index  (BMI)  of  46.8  kg/m2.  He  is  receiving  full  doses  of  guideline-directed  medial  therapy  and  is  anticoagulated.  What  is  the  potential  impact  of  obesity  on  his  clinical  cardiovascular  course  and  what  recommendations  should  the  clinician  make  regarding  weight  management  for  this  patient?